Neşe Devenot
Senior Lecturer in the University Writing Program at Johns Hopkins University
Data updated
Research Footprint
Neşe Devenot appears in 7 tracked papers (2017–2025), most studied alongside Psilocybin, MDMA and Ayahuasca, across Anxiety Disorders, Depressive Disorders and Palliative & End-of-Life Distress.
Most-cited paper: Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis (300 citations).
Frequent co-authors: Gabrielle Agin-Liebes, Stephen Ross and James Guss.
Background & Research
Neşe Devenot (they/them) is a scholar of psychedelics, bioethics, and literary studies. They earned their BA from Bard College and their MA and PhD in Comparative Literature & Literary Theory from the University of Pennsylvania, where they focused on psychedelic philosophy and the literature of chemical self-experimentation. They joined the Johns Hopkins University Writing Program in 2023 and continue to write on psychedelic ethics, policy, and harms.
Key Impact
Neşe Devenot is a notable critic and scholar of psychedelic medicine whose work examines ethics, public discourse, and the social meanings of psychedelic-assisted therapy.
Collaboration Network
28 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Neşe Devenot is associated with.
Johns Hopkins University
academicThe Centre for Psychedelic and Consciousness Research focuses on how psychedelics affect behavior, cognition, brain function, and biological health markers. They have been at the forefront of demonstrating the safety and efficacy of psychedelics for mental disorders, expanding their focus into psilocybin research across multiple mental health conditions, including smoking cessation, major depressive disorder, and cancer-related anxiety.
View stakeholder →University of Pennsylvania
The Penn Psychedelics Collaborative at the University of Pennsylvania is a multi-school consortium of researchers, clinicians, and faculty advancing transdisciplinary psychedelic science across Penn Medicine and Penn Nursing, including clinical trials of MDMA-assisted therapy and psilocybin research. Penn researchers are also leading the development of bioethical guidelines for psychedelic-assisted therapy and community implementation frameworks.
View stakeholder →